Acute interstitial nephritis in adults: A retrospective case series from a nephrology center in Tunisia

##plugins.themes.academic_pro.article.sidebar##

Published Mar 30, 2025
https://doi.org/10.62438/tunismed.v103i4.5464
Download
pdf
Vol. 103 No. 4 (2025): Tunis Med Apr 2025

##plugins.themes.academic_pro.article.main##

Sanda Mrabet
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Nermine Ben Achour
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Raja Boukadida
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Nihed Abdessaied
Department of Pathology, Farhat Hached University Hospital Sousse, Tunisia.
Asma Omezzine
Biochemistry Department, LR12SP11, Sahloul University Hospital, Sousse, Tunisia.
Asma Fradi
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Wissal Sahtout
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Awatef Azzabi
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Narjess Ben Aicha
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Nesrine Thabet
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Dorsaf Zellama
Nephrology Department, Sahloul University Hospital, Sousse, Tunisia
Moncef Mokni
Department of Pathology, Farhat Hached University Hospital Sousse, Tunisia
Ali Bouslama
Biochemistry Department, LR12SP11, Sahloul University Hospital, Sousse, Tunisia.

Abstract

Introduction-Aim: Acute interstitial nephritis (AIN) shows variability in incidence and etiology based on geography.  The study aimed to understand the characteristics and root causes of AIN, its diagnosis methods, treatment strategies, and results within a Tunisian population.


Method: We retrospectively gathered data on biopsy-proven AIN from a Nephrology center over 16 years. 


Results: We gathered 36 confirmed cases of biopsy-proven AIN. The average age of the patients was 50.58 years. The predominant clinical signs were fatigue (58%) and fever (22%). The mean level of creatinine was 691.58 µmol/l. Interstitial infiltrate was significant in 52.77% of cases, with eosinophils present in only 5.55% of cases and fibrosis noted in 27.77% of cases. Drug-related causes accounted for 46.66% of AIN cases, while infections and systemic diseases accounted for 16.66% and 11.11%, respectively. We have identified two exceptional causes of AIN, one associated with treatment with Rituximab and the other with a triple parasitic infection. Some cases (25%) lacked an identifiable cause. Corticosteroid treatment was recommended for 93.33% of cases. The median follow-up duration was 2.2 years. Seven patients required hemodialysis, and 71.42% recovered renal function. The presence of interstitial fibrosis correlated with the progression to chronic kidney disease.


Conclusion: AIN is a leading cause of acute kidney injury that can progress to chronicity. Interstitial fibrosis is associated with the progression of chronic kidney disease. The primary etiology is drug intake, and some causes are yet to be identified.

Keywords:

Nephritis, Acute kidney injury, Drug, Fibrosis, Acute interstitial nephritis

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol. 2010;6(8):461‑70.
  2. Donati A, Krishnan N. Should Corticosteroids Be Used to Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: PRO. Kidney360. 2022;3(8):1306-1309.
  3. Praga M, González E. Acute interstitial nephritis. Kidney International.2010;77(11):956-61.
  4. Caillard S, Moulin B. Néphropathie interstitielle immuno-allergiqueDrug-induced acute interstitial nephritis. Réanimation.2003;12(4):306-12.
  5. Raghavan R, Shawar S. Mechanisms of Drug-Induced Interstitial Nephritis. Adv Chronic Kidney Dis.2017;24(2):64-71.
  6. Moledina DG, Obeid W, Smith RN, Rosales I, Sise ME, Moeckel G, et al. Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. J Clin Invest. 2023;133(13):e168950.
  7. Goicoechea M, Rivera F, Lopez-Gomez JM, on behalf of all the members of the Spanish Registry of Glomerulonephritis. Increased prevalence of acute tubulointerstitial nephritis. Nephrology Dialysis Transplantation. 2013;28(1):112-5.
  8. Roy S, Awogbemi T, Holt RCL. Acute tubulointerstitial nephritis in children- a retrospective case series in a UK tertiary paediatric centre. BMC Nephrol. 2020;21(1):17.
  9. Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Biopsy-Proven Acute Interstitial Nephritis, 1993-2011: A Case Series. American Journal of Kidney Diseases. 2014;64(4):558-66.
  10. Praga M, Sevillano A, Auñón P, González E. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015;30(9):1472-9.
  11. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract. 2012;120(4):c179-84.
  12. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4S):S117-S314.
  13. Davison A. Acute interstitial nephritis in the elderly: a report from the UK MRC glomerulonephritis register and a review of the literature. Nephrology Dialysis Transplantation. 1998;13(90007):12-6.
  14. Muriithi AK, Leung N, Valeri AM, Cornell LD, Sethi S, Fidler ME, et al. Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly. Kidney International. 2015;87(2):458-64.
  15. Valluri A, Hetherington L, Mcquarrie E, Fleming S, Kipgen D, Geddes CC, et al. Acute tubulointerstitial nephritis in Scotland. QJM. 2015;108(7):527-32.
  16. Kodner CM. Diagnosis and Management of Acute Interstitial Nephritis. 2003;67(12).
  17. McCammack KC, Hawkes NC, Silverman ED, Paz DA. PET/CT appearance of acute pyelonephritis. Clin Nucl Med. 2013;38(7):e299-301.
  18. Miao J, Alexander MP, Zoghby ZM. Acute Interstitial Nephritis on Positron-Emission Tomography-Computed Tomography Imaging. Kidney Medicine. 2022;4(11):100552.
  19. Clarkson MR. Acute interstitial nephritis: clinical features and response to corticosteroid therapy. Nephrology Dialysis Transplantation.2004;19(11):2778-83.
  20. Mrabet S, Romdhane W, Fradi A, Boukadida R, Azzabi A, Guedri Y, et al. Severe Acute Interstitial Nephritis, Dermatitis, and Hemolytic Anemia due to Polyparasitic Infection in an Immunocompetent Male Patient. Am J Mens Health. 2022;16(6):15579883221139914.
  21. González E, Gutiérrez E, Galeano C, Chevia C, de Sequera P, Bernis C, et al. Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney International. 2008;73(8):940-6.
  22. Mrabet S, Dahmene R, Fradi A, Jaziri A, Boukadida R, Azzebi A, et al. Sarcoid-Like Reaction in the Kidney Following Rituximab for Mantle Lymphoma in a 60-Year-Old Man. Am J Mens Health.2023;17(2):155798832311593.
  23. Saarela V, Nuutinen M, Ala-Houhala M, Arikoski P, Rönnholm K, Jahnukainen T. Tubulointerstitial nephritis and uveitis syndrome in children: a prospective multicenter study. Ophthalmology. 2013;120(7):1476-81.
  24. Prendecki M, Tanna A, Salama AD, Tam FWK, Cairns T, Taube D, et al. Long-term outcome in biopsy-proven acute interstitial nephritis treated with steroids. Clin Kidney J. 2016;sfw116.
  25. Su T, Gu Y, Sun P, Tang J, Wang S, Liu G, et al. Etiology and renal outcomes of acute tubulointerstitial nephritis: a single-center prospective cohort study in China. Nephrology Dialysis Transplantation. 2018;33(7):1180-8.
  26. Naqvi R, Mubarak M, Ahmed E, Akhtar F, Naqvi A, Rizvi A. Acute tubulointerstitial nephritis/drug-induced acute kidney injury; an experience from a single center in Pakistan. J Renal Inj Prev. 2016;5(1):17-20.